Blue Jet Healthcare LimitedBLUEJETCorporate

Pharmaceuticals - Indian - Bulk Drugs & Formln Latest results: Jun 2026 4 quarters of data

₹520.65

MCap ₹9,031 Cr

Blue Jet Healthcare Limited — Stock analysis & AI research Blue Jet Healthcare Limited — Multibagger AI analysis Blue Jet Healthcare Limited — Seasonality — best & worst months Blue Jet Healthcare Limited — Technical indicators & charts Blue Jet Healthcare Limited — Technical setup — score, trend, support & resistance Blue Jet Healthcare Limited — Falling Wedge pattern forming Blue Jet Healthcare Limited — Live exchange announcements

🏭 Pharma sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹293 Cr

Sales · Jun 2026

-17.4% YoY

₹98 Cr

Operating Profit · Jun 2026

-18.9% YoY

33.5%

OPM % · Jun 2026

-1.8% YoY

₹78 Cr

Net Profit · Jun 2026

-14.2% YoY

₹4.51

EPS · Jun 2026

-14.3% YoY

📝 Blue Jet Healthcare Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Blue Jet Healthcare Limited reported revenue of ₹293 crore for the quarter ended June 2026 (Q1 FY27), down 17.4% from ₹355 crore in the same quarter last year.

Net profit fell 14.2% year-on-year to ₹78 crore, from ₹91 crore. Earnings per share (EPS) came in at ₹4.51.

Operating profit stood at ₹98 crore — an operating margin (OPM) of 33.5%, compared with 34.1% in the year-ago quarter.

Valuation snapshot

At the current price of ₹520.65, BLUEJET has a market capitalisation of ₹9,031 crore.

Within the Pharmaceuticals - Indian - Bulk Drugs & Formln industry, it is the 3rd-largest of the 47 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 73.15%, foreign institutional investors (FIIs) 0.82%, domestic institutional investors (DIIs) 7.49%, public shareholders 18.55% of Blue Jet Healthcare Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹9,031 Cr

Current Price ?

₹520.6

P/E ?

N/A

Industry P/E ?

37.20

P/B ?

6.64

P/S ?

N/A

P/FCF ?

78.53

Enterprise Value ?

₹9,073 Cr

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

0.23%

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

26.0%

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹293 Cr

PAT — latest qtr ?

₹78 Cr

YoY qtr sales growth ?

-17.4%

YoY qtr profit growth ?

-14.2%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹42 Cr

Debt to Equity ?

0.03

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

73.15%

Change in promoter holding ?

-12.85%

Pledged percentage ?

N/A

Market

Return 3 months ?

-10.9%

Return 6 months ?

23.2%

🗓️ Quarterly results (4 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Dec 2024	Jun 2025	Dec 2025	Jun 2026	YoY %	QoQ %
Sales	318	355	192	293	-17.4%	—
Operating Profit	124	121	47	98	-18.9%	—
Other Income	13	8	13	15	+84.6%	—
Interest	0	1	0	1	-4.3%	—
Depreciation	5	6	6	7	+17.7%	—
Profit Before Tax	132	123	54	106	-13.8%	—
Net Profit	99	91	40	78	-14.2%	—
EPS	5.71	5.26	2.32	4.51	-14.3%	—
OPM %	39.0%	34.1%	24.4%	33.5%	-1.8%	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	35	35	35	35	+0.0%
Reserves	647	811	1,098	1,325	+20.7%
Borrowings	5	3	21	42	+100.0%
Other Liabilities	176	211	263	239	-9.1%
Total Liabilities	862	1,059	1,418	1,641	+15.7%
Fixed Assets	151	172	300	316	+5.3%
CWIP	30	147	89	301	+238.2%
Investments	189	250	187	252	+34.8%
Other Assets	491	489	841	771	-8.3%
Total Assets	862	1,059	1,418	1,641	+15.7%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	142	241	46	334	+626.1%
Cash from Investing Activity	-147	-264	-35	-276	-688.6%
Cash from Financing Activity	-4	-2	-19	-31	-63.2%
Net Cash Flow	-10	-24	-8	28	+450.0%
Free Cash Flow	83	68	-34	115	+438.2%
CFO/OP	92%	109%	36%	151%	+319.4%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Days Payable	58	35	70	48	-31.4%
Debtor Days	121	91	124	131	+5.6%
Inventory Days	137	151	209	157	-24.9%
Cash Conversion Cycle	199	206	262	240	-8.4%
Working Capital Days	120	92	157	224	+42.7%
ROCE %	35%	30%	40%	26%	-35.0%

👥 Shareholding (latest 6 periods)

Metric	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Jul 2026	Sep 2026	% Chg
Promoters	79.81%	79.81%	79.81%	79.81%	73.15%	73.15%	+0.0%
FIIs	1.83%	1.14%	0.89%	0.40%	0.62%	0.82%	+32.3%
DIIs	3.63%	4.65%	4.51%	4.65%	9.12%	7.49%	-17.9%
Public	14.74%	14.41%	14.80%	15.14%	17.11%	18.55%	+8.4%
No. of Shareholders	80,117	80,187	79,199	78,917	78,927	79,390	+0.6%

⚖️ Peer comparison

Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln · top 25 of 47 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	AKUMS Akums Drugs	₹784.55	12,012	41.2	4,502	293	12.6%	6.5%	5.9%	-25.5%	13.9%	56.1%
2	STAR Strides Pharma	₹1,085.00	10,001	26.7	3,636	389	25.4%	10.7%	-20.4%	99.0%	11.2%	50.0%
3	BLUEJET Blue Jet	₹565.05	9,802	36.9	884	265	36.3%	30.0%	8.0%	0.7%	-17.5%	-14.3%
4	AARTIPHARM Aarti Pharmalabs	₹828.30	7,511	36.1	1,957	208	22.0%	10.6%	1.5%	-26.9%	42.4%	39.2%
5	SUPRIYA Supriya Lifescience	₹870.30	7,004	35.3	873	198	33.2%	22.7%	18.9%	11.1%	30.8%	-30.9%
6	INNOVACAP Innova Captab	₹1,199.30	6,863	13.8	5,779	497	14.6%	8.6%	355.1%	277.4%	33.9%	42.3%
7	MOREPENLAB Morepen Laboratories	₹123.35	6,759	48.0	1,951	141	9.4%	7.2%	-0.3%	-18.3%	34.1%	394.0%
8	IOLCP IOL Chemicals	₹201.19	5,905	35.2	2,523	168	12.3%	6.7%	11.5%	36.6%	37.1%	89.8%
9	FDC FDC	₹350.20	5,702	19.5	2,191	291	15.3%	13.3%	3.0%	4.8%	3.0%	9.5%
10	NOVARTIND Novartis India	₹2,257.80	5,575	57.0	371	97	27.6%	26.2%	-0.3%	-6.9%	18.2%	14.3%
11	ORCHPHARMA Orchid Pharma	₹1,058.75	5,370	236.9	812	22	5.1%	2.7%	-11.9%	-76.4%	0.2%	25.4%
12	RPGLIFE RPG Life	₹2,865.90	4,740	39.7	735	120	21.1%	16.3%	8.4%	-36.9%	15.8%	16.3%
13	ZOTA Zota Health	₹1,232.70	4,269	—	609	-104	0.6%	-17.1%	84.6%	-29.8%	66.9%	-213.9%
14	GUFICBIO Gufic Biosciences	₹419.85	4,210	57.3	974	74	16.9%	7.6%	14.7%	-9.1%	14.9%	86.0%
15	UNICHEMLAB Unichem Laboratories	₹526.70	3,708	12.2	2,308	305	9.9%	13.2%	6.2%	74.1%	20.1%	496.1%
16	INDSWFTLAB Ind-Swift Laboratories	₹374.00	3,252	55.4	665	57	9.0%	8.6%	235.3%	10.1%	32.3%	-88.7%
17	ADVENZYMES Advanced Enzyme	₹293.25	3,249	19.8	750	172	29.8%	22.9%	17.1%	29.6%	2.1%	-4.6%
18	SOLARA Solara Active	₹667.00	3,218	85.6	1,535	37	15.2%	2.4%	6.6%	-1470.4%	33.1%	381.8%
19	DCAL Dishman Carbogen	₹162.08	2,541	157.6	2,902	16	16.7%	0.6%	8.1%	2655.7%	-4.3%	-351.7%
20	INDOCO Indoco Remedies	₹254.59	2,347	n/m	1,872	3	8.8%	0.2%	10.7%	-26.5%	6.5%	280.0%
21	PANACEABIO Panacea Biotec	₹368.55	2,257	—	673	-9	0.3%	-1.3%	14.4%	17.9%	19.7%	-44.4%
22	REMUS Remus Pharma.	₹1,911.30	2,252	91.1	94	25	31.7%	26.7%	—	—	13.3%	21.4%
23	SAKAR Sakar Healthcare	₹987.40	2,167	61.0	272	36	28.5%	13.3%	41.9%	71.8%	38.4%	120.2%
24	JAGSNPHARM Jagsonpal Pharmaceuticals	₹227.53	1,501	33.3	294	45	20.7%	15.4%	6.9%	-22.2%	8.5%	20.4%
25	KOPRAN Kopran	₹281.55	1,361	54.5	700	25	8.7%	3.6%	-96.0%	-97.6%	13.9%	-10.0%

❓ Frequently asked questions

What was Blue Jet Healthcare Limited's revenue in Q1 FY27?